US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

VanEck Biotech ETF

243.73

+3.321.38%

Volume:10K

Turnover:2.39M

Market Cap:481.73M

PE:- -

High:244.35

Open:240.22

Low:240.22

Close:240.41

52wk High:244.35

52wk Low:160.91

Shares:1.98M

Float Shares:1.98M

Volume Ratio:0.71

T/O Rate:0.50%

Dividend:0.95

Dividend Rate:0.39%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Funds: What a Top Biotech Fund is Buying Now

Gilead Director Jeffrey Bluestone Disposes of 5,000 Common Shares Worth $727,333.60

Moderna Inc. Stock Advances 8.9%, Outperforms Peers

Gilead Declares Q3 2026 Dividend of R$ 0.24 Per Unit

Amgen Advances Tarlatamab Shot vs. Infusion in Phase 3 Lung Cancer Study

Regeneron Stock (REGN) Buckling as Shareholders Sue Over Cancer Drug Claims

Revolution Medicines, Inc. : Bernstein Raises Target Price to $179 from $151

THOMSON REUTERS

Gilead (GILD) Stock Still Looks Below Fair Value As Court Backs HIV Import Block

Simply Wall St.

Gilead Sciences Inc. Stock Underperforms Thursday When Compared to Competitors

Moderna Inc. Stock Slips 23.5%, Underperforms Peers

Revolution Medicines Advances RASolve 308 Lung Cancer Trial, Raising Long-Term Upside Potential for RVMD

Vertex Advances Kidney Disease Pipeline With Completed Inaxaplin Phase 2b Trial

Wall Street Analysts Are Bullish on Top Healthcare Picks

Sino Biopharmaceutical Stock Climbs 13% in Hong Kong, Outperforms Competitors

Sweden's Medivir Q2 Turnover Falls

Vertex Resource Group Boosts Profitability and Cash Flow in Q2 2026

Telix Swings to H1 FY26 Net Profit of US$38 Million; Revenue Rises 22% to Us$477 Million

Press Release: Vertex Resource Group Ltd. Reports Second Quarter 2026 Results

Crinetics Faces Shareholder Challenges to Vertex Merger Deal

Moderna Inc. Stock Rallies 177.0%, Outperforms Peers

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/stock/BBH/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BBH","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BBH\",,,,,undefined,":{"symbol":"BBH","market":"US","secType":"STK","nameCN":"VanEck Biotech ETF","latestPrice":243.7264,"timestamp":1787688000000,"preClose":240.41,"halted":0,"volume":9843,"delay":0,"changeRate":0.013794767272576081,"floatShares":1976503,"shares":1976503,"eps":0,"marketStatus":"Pre-Mkt","change":3.3164,"latestTime":"08-26 06:13:20 EDT","open":240.22,"high":244.345,"low":240.22,"amount":2394036.2130299998,"amplitude":0.017158,"askPrice":389.96,"askSize":200,"bidPrice":220,"bidSize":100,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1787751000000},"marketStatusCode":1,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":243.7264,"sharesOutstanding":1976503,"nav":240.10472,"aum":474567706.07,"dividendRate":0.0039,"bidAskSpread":0.00128,"postHourTrading":{"tag":"盘后","latestPrice":243.48,"preClose":243.7264,"latestTime":"19:30 EDT","volume":15,"amount":3655.9176,"timestamp":1787700602077,"change":-0.2464,"changeRate":-0.001011,"amplitude":0},"volumeRatio":0.7131678430215547,"impliedVol":0.2069,"impliedVolPercentile":0.72},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BBH\",,,,,undefined,":{"symbol":"BBH","floatShares":1976503,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.7131678430215547,"shares":1976503,"dividePrice":0.9505,"high":244.345,"amplitude":0.017158,"preClose":240.41,"low":240.22,"week52Low":160.91,"pbRate":"--","week52High":244.345,"institutionHeld":0,"latestPrice":243.7264,"committee":-0.333333,"eps":0,"divideRate":0.0039,"volume":9843,"delay":0,"ttmEps":0,"open":240.22,"prevYearClose":189.2649,"prevWeekClose":241.2282,"prevMonthClose":205.5494,"prevQuarterClose":203.2373,"fiveDayClose":224.4799,"twentyDayClose":210.0993,"sixtyDayClose":188.64},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BBH\",params:#limit:5,,,undefined,":[{"date":"2025-12-22","symbol":"BBH","amount":0.9565,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"VanEck Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-26","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-26"},{"date":"2024-12-23","symbol":"BBH","amount":1.2517,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-23","defaultRemindTime":1734964200000,"name":"VanEck Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-24","payableDate":"2024-12-23","currency":"USD","dateTimestamp":1734930000000,"payDate":"2024-12-24"},{"date":"2023-12-18","symbol":"BBH","amount":0.7127,"announcedDate":"2023-12-15","type":"dividend","market":"US","newRecordDate":"2023-12-19","defaultRemindTime":1702909800000,"name":"VanEck Biotech ETF","recordDate":"2023-12-22","payableDate":"2023-12-19","currency":"USD","dateTimestamp":1702875600000,"payDate":"2023-12-22"},{"market":"US","date":"2022-12-19","symbol":"BBH","amount":0.7488,"defaultRemindTime":1671460200000,"name":"VanEck Biotech ETF","recordDate":"2022-12-23","payableDate":"2022-12-20","currency":"USD","type":"dividend","dateTimestamp":1671426000000},{"market":"US","date":"2021-12-20","symbol":"BBH","amount":0.3972,"defaultRemindTime":1640010600000,"name":"VanEck Vectors Biotech ETF","recordDate":"2021-12-27","payableDate":"2021-12-21","currency":"USD","type":"dividend","dateTimestamp":1639976400000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BBH\",market:\"US\",,,undefined,":[{"executeDate":"2016-12-19","recordDate":"2016-12-21","paymentDate":"2016-12-23","value":0.327,"currency":"USD"},{"executeDate":"2018-12-20","recordDate":"2018-12-21","paymentDate":"2018-12-27","value":0.006,"currency":"USD"},{"executeDate":"2019-12-23","recordDate":"2019-12-24","paymentDate":"2019-12-30","value":0.4724,"currency":"USD"},{"executeDate":"2020-12-21","recordDate":"2020-12-22","paymentDate":"2020-12-28","value":0.6079,"currency":"USD"},{"executeDate":"2021-12-20","recordDate":"2021-12-21","paymentDate":"2021-12-27","value":0.3972,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BBH\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BBH\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2661213210","title":"Funds: What a Top Biotech Fund is Buying Now","url":"https://stock-news.laohu8.com/highlight/detail?id=2661213210","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661213210?lang=en_us&edition=fundamental","pubTime":"2026-08-22 09:30","pubTimestamp":1787362200,"startTime":"0","endTime":"0","summary":"It's hard to find a more experienced biotech investor than Evan McCulloch. The manager of Franklin Biotechnology Discovery has been running the $1.2 billion fund since 1997.That matters in this highly","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1057294990.SGD","IE00B19Z3B42.SGD","IE00BKVL7J92.USD","LU1839511570.USD","IE00BZ9MQY76.HKD","LU0965509101.SGD","LU0882574055.USD","LU1934455863.HKD","BK4007","IE00BN0W2V16.EUR","LU0320765992.SGD","SG9999015986.USD","LU2456880835.USD","04332","LU1023059063.AUD","LU0061475181.USD","LU0861579265.USD","LU1061106388.HKD","IE00B19Z9P08.USD","BK4139","LU2112291526.USD","AMGN","LU1917777945.USD","BK4532","LU1066053197.SGD","LU2087621335.USD","LU0432979614.USD","LU1778281490.HKD","LU1035775433.USD","BK4583","TBXU","LU0965509010.AUD","LU1585245621.USD","SG9999013999.USD","IE00B3T34201.USD","LU2324357040.USD","VRTX","LU2362540622.SGD","SG9999015952.SGD","LU0823434583.USD","LU0058720904.USD","LU2089984988.USD","LU0868494617.USD","LU1983299246.USD","PBE","SG9999001176.USD","LU0109394709.USD","IE00BSNM7G36.USD","LU0965509283.SGD","LU1093756325.SGD","BK4567","LU1093756168.USD","GNMX","LU1674673691.USD","LU2106854487.HKD","IE00BFTCPJ56.SGD","LU0889565916.HKD","LU0256863811.USD","REGN","LU1037948897.HKD","LU2023250504.SGD","IE00B2B36J28.USD","LU0965508806.USD","BK4578","LU0053666078.USD","IBB","LU0859254822.USD","LU1430594728.SGD","MEDI","LU0289739699.SGD","IE00BN0W2W23.USD","LU0234570918.USD","LU1571399168.USD","LU2236285917.USD","BMED","BK4550","LU0823434740.USD","BIB","IE00B7SZLL34.SGD","BK4599","IBBQ","LU0417517546.SGD","LU0114720955.EUR","LU1066051498.USD","IE00B19Z3581.USD","IE0002270589.USD","IDNA","IE00BN0W2T93.GBP","BK4566","LU1037948541.HKD","LU2462157665.USD","LU0154245673.USD","LU2237438978.USD","LU1934455277.USD","IE00BZ1G4Q59.USD","LU2357627491.SGD","SG9999015978.USD","IE00BJT1NW94.SGD","LU2468319806.SGD","LU1974910355.USD","BK4581","LU1934455194.USD","LU2242652126.USD","LU2242646821.SGD","XBI","LU0823416689.USD","LU2362541273.HKD","IE0002141913.USD","BK4534","BK4533","LU1674673428.USD","IE00BJJMRZ35.SGD","GILD","BK4588","BK4568","SGXZ57979304.SGD","LU0122379950.USD","LU2417539215.USD","PJP","IE00B894F039.SGD","IE00B19Z9Z06.USD","LU0079474960.USD","IE0009355771.USD","LU0154245756.USD","LU2362541513.USD","IE00B4R5TH58.HKD","LU1069344957.HKD","TMED","BK4585","SG9999015945.SGD","JAZZ","SG9999001176.SGD","BBH","SG9999001440.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661187372","title":"Gilead Director Jeffrey Bluestone Disposes of 5,000 Common Shares Worth $727,333.60","url":"https://stock-news.laohu8.com/highlight/detail?id=2661187372","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661187372?lang=en_us&edition=fundamental","pubTime":"2026-08-22 07:22","pubTimestamp":1787354576,"startTime":"0","endTime":"0","summary":"Gilead director Jeffrey Bluestone disposes of 5,000 common shares worth $727,333.60Gilead director Jeffrey Bluestone exercised stock options on Aug. 20, 2026, acquiring 5,000 shares at USD 61.35 to US","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260821:nNDL4cgVd7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Gilead Director Jeffrey Bluestone Disposes of 5,000 Common Shares Worth $727,333.60","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BIB","LU0965508806.USD","LU2089984988.USD","LU2468319806.SGD","LU0320765992.SGD","LU1023059063.AUD","TBXU","LU1057294990.SGD","IE00B19Z3581.USD","IBB","SG9999015986.USD","SG9999015945.SGD","BK4566","LU1674673428.USD","BK4532","LU0234570918.USD","LU1934455863.HKD","IE00B3T34201.USD","BK4568","GILD","LU0122379950.USD","BK4583","LU0965509010.AUD","LU0058720904.USD","LU2357627491.SGD","IBBQ","LU0965509283.SGD","BK4588","LU1430594728.SGD","LU2087621335.USD","SG9999015978.USD","LU1585245621.USD","BMED","BBH","MEDI","LU1778281490.HKD","LU0882574055.USD","LU0861579265.USD","LU0289739699.SGD","LU1066053197.SGD","LU1571399168.USD","SG9999015952.SGD","TMED","LU0965509101.SGD","BK4139","LU1674673691.USD","IE00B19Z3B42.SGD","LU0859254822.USD","IE00BSNM7G36.USD","IE00B7SZLL34.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661972042","title":"Moderna Inc. Stock Advances 8.9%, Outperforms Peers","url":"https://stock-news.laohu8.com/highlight/detail?id=2661972042","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661972042?lang=en_us&edition=fundamental","pubTime":"2026-08-22 04:33","pubTimestamp":1787344380,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Moderna Inc. rose 8.9% to $145.13 on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ Composite Index rising 0.4% to 26,180.45 and the Dow Jones Industrial Average rising 1.0% to 53,277.01.Moderna Inc. closed 17.8% below its 52-week high of $176.66, which the company reached on August 19th.The stock outperformed some of its peers, as Johnson & Johnson rose 1.1% to $270.24, Pfizer Inc. rose 1.0% to $28.07, and Gilead Sciences Inc. rose 1.87% to $146.12.Trading volume totaled 86.7 million, compared to the 50-day average of 13.0 million.Data source: Dow Jones Market Data, FactSet","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BIB","LU0965508806.USD","LU0320765992.SGD","TBXU","MRNA","LU1057294990.SGD","GNOM","IBB","SG9999015986.USD","LU2112291526.USD","MRNY","BK4532","LU1037948541.HKD","LU1934455194.USD","LU1061106388.HKD","LGHT","LU1934455863.HKD","GILD","LU0122379950.USD","LU2357627491.SGD","BK4583","IDNA","LU0058720904.USD","BK4585","IBBQ","LU2324357040.USD","BK4551","LU1430594728.SGD","SG9999015978.USD","WDNA","LU1585245621.USD","BK4501","BMED","BBH","LU0823416689.USD","MEDI","IE0002270589.USD","LU1839511570.USD","MRNX","LU0861579265.USD","LU0289739699.SGD","LU1066053197.SGD","LU1571399168.USD","SG9999015952.SGD","TMED","LU0234570918.USD","LU1674673691.USD","LU0965509283.SGD","LU0965509010.AUD","BK4550"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661940352","title":"Gilead Declares Q3 2026 Dividend of R$ 0.24 Per Unit","url":"https://stock-news.laohu8.com/highlight/detail?id=2661940352","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661940352?lang=en_us&edition=fundamental","pubTime":"2026-08-22 01:58","pubTimestamp":1787335117,"startTime":"0","endTime":"0","summary":"Gilead declares Q3 2026 dividend of R$ 0.24 per unitGilead Sciences set a Q3 2026 distribution of R$ 0.24 per unit for BRGILDBDR 000.Last day to trade with rights: Sept. 11, 2026.Payment date: Oct. 5,","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260821:nNDL12Yy9R:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2089984988.USD","IE00B19Z3B42.SGD","IE00B7SZLL34.SGD","IE00B3T34201.USD","IBBQ","LU0823416689.USD","LU0965509010.AUD","LU0965509283.SGD","BK4532","LU1585245621.USD","LU2112291526.USD","LU1674673428.USD","LU1061106388.HKD","BK4550","BK4588","BK4578","LU0859254822.USD","MEDI","BBH","IBB","LU0882574055.USD","LU1037948541.HKD","GILD","IE00BSNM7G36.USD","BK4583","BK4585","BIB","LU1674673691.USD","LU2357627491.SGD","LU2468319806.SGD","SG9999015986.USD","TMED","IE00BKVL7J92.USD","LU0965508806.USD","BK4139","LU1430594728.SGD","LU0889565916.HKD","BK4568","LU0965509101.SGD","LU2324357040.USD","LU0122379950.USD","LU1023059063.AUD","BMED","LU1037948897.HKD","IE0002270589.USD","LU0114720955.EUR","LU0320765992.SGD","TBXU","LU1066053197.SGD","SG9999015952.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661887294","title":"Amgen Advances Tarlatamab Shot vs. Infusion in Phase 3 Lung Cancer Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2661887294","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661887294?lang=en_us&edition=fundamental","pubTime":"2026-08-22 00:34","pubTimestamp":1787330049,"startTime":"0","endTime":"0","summary":"Amgen Inc ($AMGN) announced an update on their ongoing clinical study. Amgen’s new Phase 3 DeLLphi-315 study tests its cancer drug tarlatamab in pe...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/amgen-advances-tarlatamab-shot-vs-infusion-in-phase-3-lung-cancer-study?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/amgen-advances-tarlatamab-shot-vs-infusion-in-phase-3-lung-cancer-study?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00B2B36J28.USD","BK4599","LU0289739699.SGD","IE00BJT1NW94.SGD","IE0009355771.USD","LU2468319806.SGD","BK4566","AMGN","LU0320765992.SGD","LU0109394709.USD","LU2242646821.SGD","BK4581","IBB","BK4585","TBXU","IE00BJJMRZ35.SGD","BK4139","SG9999001440.SGD","LU1061106388.HKD","BK4588","LU0058720904.USD","LU0868494617.USD","LU2112291526.USD","PBE","LU2242652126.USD","PJP","LU1571399168.USD","IE0002141913.USD","BK4533","BBH","IE00BFTCPJ56.SGD","LU1023059063.AUD","LU1983299246.USD","LU2089984988.USD","LU0889565916.HKD","BIB","IE00B4R5TH58.HKD","IBBQ","LU1057294990.SGD","LU0122379950.USD","BK4534"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661260437","title":"Regeneron Stock (REGN) Buckling as Shareholders Sue Over Cancer Drug Claims","url":"https://stock-news.laohu8.com/highlight/detail?id=2661260437","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661260437?lang=en_us&edition=fundamental","pubTime":"2026-08-21 19:58","pubTimestamp":1787313533,"startTime":"0","endTime":"0","summary":"A class action lawsuit was filed against biotechnology company Regeneron ($REGN) on July 16, which could put further pressure on its troubled share...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/regeneron-stock-regn-buckling-as-shareholders-sue-over-cancer-drug-claims?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/regeneron-stock-regn-buckling-as-shareholders-sue-over-cancer-drug-claims?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0320765992.SGD","LU1974910355.USD","DARP","JDOC","LU0058720904.USD","LU0053666078.USD","XT","IBBQ","LU0882574055.USD","AGNG","LU2468319806.SGD","LU1917777945.USD","BK4585","SYNB","RSPH","BK4588","BBP","LU0289739699.SGD","LU0823434583.USD","LU0889565916.HKD","LU2106854487.HKD","LU2362540622.SGD","REGN","LU0823416689.USD","LU2362541513.USD","LU2089984988.USD","LU0114720955.EUR","LNGR","FWD","TBXU","BBH","LU2237438978.USD","BK4139","IBB","LU2362541273.HKD","LU0823434740.USD","FHLC","IEIH","LU2023250504.SGD","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661302269","title":"Revolution Medicines, Inc. : Bernstein Raises Target Price to $179 from $151","url":"https://stock-news.laohu8.com/highlight/detail?id=2661302269","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661302269?lang=en_us&edition=fundamental","pubTime":"2026-08-21 17:36","pubTimestamp":1787304996,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260821:nFWN44I052:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE00B2B36J28.USD","LU0889565916.HKD","RVMD","IE00BJT1NW94.SGD","IE0009355771.USD","IE0002141913.USD","IE0009354923.USD","IE00BJJMRZ35.SGD","BK4139","IE00B4R5TH58.HKD","LU0320765992.SGD","BBH","IE00BFTCPJ56.SGD","IDNA","CANC","LU0109394709.USD","PTH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661923014","title":"Gilead (GILD) Stock Still Looks Below Fair Value As Court Backs HIV Import Block","url":"https://stock-news.laohu8.com/highlight/detail?id=2661923014","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661923014?lang=en_us&edition=fundamental","pubTime":"2026-08-21 04:35","pubTimestamp":1787258134,"startTime":"0","endTime":"0","summary":"Gilead Sciences stock has delivered very strong long term returns over the past five years, yet current valuation checks and market multiples still point to the shares screening as undervalued. With recent news flow focused on its HIV and oncology franchises and on legal protection of its U.S. drug pricing, investors are weighing how much of this is already reflected in the price.\n\nGilead Sciences has returned 148.1% over the past five years, which puts recent valuation questions in the...","market":"sg","thumbnail":"https://images.simplywall.st/asset/company-cover/29002-main-header/1756252861953","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/29002-main-header/1756252861953"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-gild/gilead-sciences/news/gilead-gild-stock-still-looks-below-fair-value-as-court-back","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-gild/gilead-sciences/news/gilead-gild-stock-still-looks-below-fair-value-as-court-back","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BIB","DAPP","TSPA","BK4585","LU1778281490.HKD","BBH","MEDI","LU1934455863.HKD","BK4550","GILD","LU0861579265.USD","LU2468319806.SGD","IE00B19Z3581.USD","LU1934455194.USD","LU1066051498.USD","LU0965509010.AUD","BK4588","CDIG","IE00BSNM7G36.USD","LU0320765992.SGD","LU1037948897.HKD","LU0122379950.USD","IE00B19Z3B42.SGD","LU1934455277.USD","LU2112291526.USD","LU0823416689.USD","TMED","IE0002270589.USD","LU1037948541.HKD","LU0889565916.HKD","LU1430594728.SGD","LU2087621335.USD","SG9999015978.USD","TBXU","LU0289739699.SGD","SG9999015945.SGD","LU0109394709.USD","LU0114720955.EUR","LU1057294990.SGD","LU2089984988.USD","IE00BKVL7J92.USD","IBB","IBBQ","LU0965508806.USD","IE00BZ1G4Q59.USD","SG9999015986.USD","TACU","BK4566","BMED","LU0965509283.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661232279","title":"Gilead Sciences Inc. Stock Underperforms Thursday When Compared to Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2661232279","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661232279?lang=en_us&edition=fundamental","pubTime":"2026-08-21 04:35","pubTimestamp":1787258100,"startTime":"0","endTime":"0","summary":"DJ Gilead Sciences Inc. Stock Underperforms Thursday When Compared To CompetitorsThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Gilead Sciences Inc.  slipped 2.82% to $143.44 Thursday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index  falling 0.87% to 7,641.16 and Dow Jones Industrial Average  falling 1.32% to 52,759.21.The stock's fall snapped a seven-day winning streak.Gilead Sciences Inc. closed 8.81% below its 52-week high of $157.29, which the company achieved on February 11th.The stock underperformed when compared to some of its competitors Thursday, as Johnson & Johnson  fell 2.21% to $267.37, Pfizer Inc.  fell 1.59% to $27.79, and Abbott Laboratories  fell 0.25% to $114.14.Trading volume  remained 286,153 below its 50-day average volume of 7.4 M.Data source: Dow Jones Market Data, FactSet. Data compiled August 20, 2026.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BSNM7G36.USD","LU1571399168.USD","LU0058720904.USD","IE00B7SZLL34.SGD","BMED","IE00B3T34201.USD","LU0965509101.SGD","LU0965509283.SGD","LU1037948897.HKD","LU1934455277.USD","MEDI","IE00B19Z3B42.SGD","BK4139","IE00BKVL7J92.USD","LU0122379950.USD","LU2089984988.USD","LU0289739699.SGD","LU1934455194.USD","BK4566","LU1066051498.USD","LU1778281490.HKD","LU0861579265.USD","LU1674673691.USD","SG9999015945.SGD","BIB","LU1934455863.HKD","BK4588","LU1037948541.HKD","LU2087621335.USD","IBBQ","BK4550","BK4568","BBH","LU2112291526.USD","LU1023059063.AUD","LU1430594728.SGD","IE00BZ1G4Q59.USD","LU0114720955.EUR","BK4532","TBXU","LU0882574055.USD","LU0965508806.USD","LU0109394709.USD","LU2468319806.SGD","SG9999015978.USD","BK4583","GILD","LU1061106388.HKD","LU0965509010.AUD","LU1057294990.SGD","LU1839511570.USD","LU1674673428.USD","BK4585","LU1066053197.SGD","LU0823416689.USD","LU0889565916.HKD","TMED","BK4578","IBB","IE0002270589.USD","LU0234570918.USD","LU2324357040.USD","LU0320765992.SGD","SG9999015952.SGD","LU1585245621.USD","SG9999015986.USD","IE00B19Z3581.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661232427","title":"Moderna Inc. Stock Slips 23.5%, Underperforms Peers","url":"https://stock-news.laohu8.com/highlight/detail?id=2661232427","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661232427?lang=en_us&edition=fundamental","pubTime":"2026-08-21 04:33","pubTimestamp":1787257980,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Moderna Inc. cratered 23.5% to $133.32 on what proved to be an all-around rough trading session for the stock market, with the NASDAQ Composite Index falling 1.0% to 26,067.17 and Dow Jones Industrial Average falling 1.3% to 52,759.21.Moderna Inc. closed 24.5% short of its 52-week high of $176.66, which the company reached on August 19th.The stock underperformed when compared to some of its peers, as Johnson & Johnson fell 2.2% to $267.37, Pfizer Inc. fell 1.6% to $27.79, and Gilead Sciences Inc. fell 2.82% to $143.44.Trading volume totaled 97.3 million, compared to the 50-day average of 11.2 million.Data source: Dow Jones Market Data, FactSet","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BSNM7G36.USD","BBH","MEDI","IBBQ","IDNA","LU1023059063.AUD","BK4533","BK4566","IE00B3T34201.USD","LU1674673428.USD","LU1778281490.HKD","TBXU","IE00B7SZLL34.SGD","BMED","BK4551","WDNA","LU1066053197.SGD","LU2468319806.SGD","BIB","MRNX","LGHT","LU1585245621.USD","LU1037948541.HKD","BK4578","LU1430594728.SGD","MRNY","SG9999015952.SGD","LU0882574055.USD","LU0965509010.AUD","LU1674673691.USD","LU0289739699.SGD","LU1839511570.USD","BK4548","LU0823416689.USD","GNOM","LU0058720904.USD","BK4532","LU2112291526.USD","MRNA","TMED","GILD","LU0114720955.EUR","IBB","BK4139","LU1934455194.USD","LU2324357040.USD","LU0109394709.USD","IE00B19Z3B42.SGD","BK4550","SG9999015945.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661236908","title":"Revolution Medicines Advances RASolve 308 Lung Cancer Trial, Raising Long-Term Upside Potential for RVMD","url":"https://stock-news.laohu8.com/highlight/detail?id=2661236908","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661236908?lang=en_us&edition=fundamental","pubTime":"2026-08-21 00:31","pubTimestamp":1787243464,"startTime":"0","endTime":"0","summary":"Revolution Medicines, Inc. ($RVMD) announced an update on their ongoing clinical study. This phase 3 study, titled “A Randomized, Double-blind, Pha...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/revolution-medicines-advances-rasolve-308-lung-cancer-trial-raising-long-term-upside-potential-for-rvmd?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/revolution-medicines-advances-rasolve-308-lung-cancer-trial-raising-long-term-upside-potential-for-rvmd?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00B4R5TH58.HKD","CANC","IDNA","IE0009354923.USD","IE00BJT1NW94.SGD","LU0320765992.SGD","IE00BJJMRZ35.SGD","IE0002141913.USD","IE0009355771.USD","LU0109394709.USD","IE00BFTCPJ56.SGD","BK4139","PTH","RVMD","LU0889565916.HKD","BBH","IE00B2B36J28.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661323699","title":"Vertex Advances Kidney Disease Pipeline With Completed Inaxaplin Phase 2b Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2661323699","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661323699?lang=en_us&edition=fundamental","pubTime":"2026-08-21 00:30","pubTimestamp":1787243431,"startTime":"0","endTime":"0","summary":"Vertex Pharmaceuticals Inc. ($VRTX) announced an update on their ongoing clinical study. The Phase 2b study A Phase 2b, Open-label Study to Evaluat...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/vertex-advances-kidney-disease-pipeline-with-completed-inaxaplin-phase-2b-trial?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/vertex-advances-kidney-disease-pipeline-with-completed-inaxaplin-phase-2b-trial?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0234570918.USD","IE00B2B36J28.USD","LU1815336091.USD","IE0002141913.USD","LU2456880835.USD","LU2324357040.USD","IBBQ","LU2362541513.USD","BBH","SG9999001176.USD","LU0757428866.USD","TBXU","VERX","BIB","BK4588","IE00B19Z3B42.SGD","IE00B19Z9P08.USD","LU1069344957.HKD","LU1674673428.USD","IE00BFTCPJ56.SGD","LU1674673691.USD","LU2237438978.USD","IBB","GNMX","LU1093756325.SGD","IDNA","LU0566484027.USD","SGXZ57979304.SGD","LU0289739699.SGD","LU2468319806.SGD","IE00BJJMRZ35.SGD","LU2417539215.USD","IE0009355771.USD","LU2362540622.SGD","SG9999013999.USD","LU0889565916.HKD","BK4139","LU0256863811.USD","PBE","LU1093756168.USD","IE00B894F039.SGD","SG9999001176.SGD","VRTX","BK4567","LU0432979614.USD","LU2362541273.HKD","LU0079474960.USD","IE00B19Z3581.USD","LU2089984988.USD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660728971","title":"Wall Street Analysts Are Bullish on Top Healthcare Picks","url":"https://stock-news.laohu8.com/highlight/detail?id=2660728971","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660728971?lang=en_us&edition=fundamental","pubTime":"2026-08-20 19:40","pubTimestamp":1787226007,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Vertex Pharmaceuticals (VRTX), Glaukos (GKOS) and Ve...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-healthcare-picks-blurbs-news-306?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-healthcare-picks-blurbs-news-306?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1778281490.HKD","LU2462157665.USD","BK4585","BBH","GNMX","IE0002270589.USD","IE00B19Z3581.USD","IE00B4R5TH58.HKD","LU1035775433.USD","LU1878469433.USD","PBE","LU1674673428.USD","LU2237438978.USD","IE00BJJMRZ35.SGD","IBBQ","LU0109394709.USD","IE00B19Z3B42.SGD","LU2362541513.USD","LU2417539215.USD","LU2468319806.SGD","SG9999001176.USD","BK4548","LU2456880835.USD","VRTX","BK4082","LU1585245621.USD","IE00BZ9MQY76.HKD","SGXZ57979304.SGD","LU0889565916.HKD","LU1674673691.USD","LU0079474960.USD","LU1069344957.HKD","LU0432979614.USD","LU1430594728.SGD","SG9999001176.SGD","BK4588","LU0823416689.USD","IE0002141913.USD","IDNA","LU2362541273.HKD","LU0256863811.USD","BK4532","IE00BFTCPJ56.SGD","LU0417517546.SGD","LU0058720904.USD","LU2236285917.USD","TBXU","IE0009354923.USD","IE0009355771.USD","LU2089984988.USD","LU0289739699.SGD","SG9999013999.USD","IBB","IE00B19Z9P08.USD","LU0320765992.SGD","BK4533","BIB","LU2065731478.USD","GKOS","LU2324357040.USD","LU0234570918.USD","IE00B894F039.SGD","LU1093756325.SGD","IE00BJT1NW94.SGD","LU0061475181.USD","BK4567","IE00B19Z9Z06.USD","LU1093756168.USD","LU2362540622.SGD","BK4139","IE00B2B36J28.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660402506","title":"Sino Biopharmaceutical Stock Climbs 13% in Hong Kong, Outperforms Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2660402506","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660402506?lang=en_us&edition=fundamental","pubTime":"2026-08-20 16:31","pubTimestamp":1787214660,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Sino Biopharmaceutical Ltd. surged 13% to 5.39 Hong Kong dollars on what proved to be an all-around great trading session for the Hong Kong stock market, with the Hang Seng Index rising 0.8% to 25698.49.The stock's rise snapped a two-day losing streak.Sino Biopharmaceutical Ltd. closed 41% short of its 52-week high of HK$9.12, which the company achieved Sept. 10.The stock outperformed some of its competitors, as CSPC Pharmaceutical Group Ltd. rose 9.6% and Amgen Inc. remained unchanged.Trading volume totaled 382.5 million shares, compared to the 50-day average of 95.1 million shares.Data source: Dow Jones Market Data, FactSet","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2089984988.USD","IE0009355771.USD","IBB","BK1515","IE00BZ08YT58.USD","BBH","BK4534","IE00BFTCPJ56.SGD","LU0289739699.SGD","IE00BJJMRZ35.SGD","BK4588","BK1589","LU2112291526.USD","LU2468319806.SGD","LU0889565916.HKD","IE00BJT1NW94.SGD","BIB","IE00B4R5TH58.HKD","LU1057294990.SGD","BK4599","PJP","LU0122379950.USD","SG9999001440.SGD","01177","BK4566","LU0109394709.USD","HK0000165453.HKD","IE0002141913.USD","IE00B2B36J28.USD","IBBQ","LU0058720904.USD","LU1023059063.AUD","LU1061106388.HKD","LU0320765992.SGD","BK4581","BK4585","LU2242652126.USD","BK1191","IE00BZ08YR35.GBP","LU2242646821.SGD","AMGN","BK1521","LU0868494617.USD","IE00BZ08YS42.EUR","TBXU","LU1571399168.USD","PBE","LU1983299246.USD","BK4533","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660340609","title":"Sweden's Medivir Q2 Turnover Falls","url":"https://stock-news.laohu8.com/highlight/detail?id=2660340609","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660340609?lang=en_us&edition=fundamental","pubTime":"2026-08-20 14:41","pubTimestamp":1787208103,"startTime":"0","endTime":"0","summary":"Sweden's Medivir Q2 turnover fallsOverviewSweden drug developer's Q2 net turnover declined yr/yr, EBITDA loss narrowedCompany completed SEK 140 mln share issue to fund rare bone disease drug developme","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260820:nL1N44H07I:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBBQ","LU1720051108.HKD","LU0963586101.USD","LU2023250504.SGD","LU0289739699.SGD","LU1720051017.SGD","BK4585","LU0889565916.HKD","LU2362540622.SGD","LU2362541273.HKD","LU0511384066.AUD","LU2357305700.SGD","LU1992135472.HKD","LU1366192091.USD","LU2106854487.HKD","LU0069063385.USD","BK4139","BK4588","LU0823434740.USD","LU0058720904.USD","LU0114720955.EUR","LU2362541513.USD","BK4512","LU1974910355.USD","LU0053666078.USD","REGN","LU0109394709.USD","LU0289739343.SGD","LU2473716301.USD","LU0823416689.USD","LU0289960550.SGD","FLEX","LU0320765489.SGD","LU2272731782.SGD","LU2322448957.HKD","LU2468319806.SGD","LU2322448791.USD","LU2237438978.USD","LU0057025933.USD","BBH","FLEL","LU0823434583.USD","LU1303367103.USD","LU2089984988.USD","LU2272731600.USD","LU2272731865.HKD","LU0208291251.USD","IBB","LU1917777945.USD","TBXU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660479477","title":"Vertex Resource Group Boosts Profitability and Cash Flow in Q2 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2660479477","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660479477?lang=en_us&edition=fundamental","pubTime":"2026-08-20 07:37","pubTimestamp":1787182673,"startTime":"0","endTime":"0","summary":"Vertex Resource Group Ltd. ( ($TSE:VTX) ) has issued an update. Vertex Resource Group Ltd. reported stronger second-quarter 2026 results, highlight...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/vertex-resource-group-boosts-profitability-and-cash-flow-in-q2-2026?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/vertex-resource-group-boosts-profitability-and-cash-flow-in-q2-2026?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0256863811.USD","LU0889565916.HKD","IDNA","IBB","IE0002141913.USD","LU0566484027.USD","GNMX","VRTX","LU2462157665.USD","BK4588","LU0320765992.SGD","SG9999013999.USD","VERX","LU2362541513.USD","SGXZ57979304.SGD","PBE","LU0234570918.USD","LU1093756168.USD","IE00B19Z9Z06.USD","LU0289739699.SGD","LU0061475181.USD","BK4533","LU0058720904.USD","IE00BZ9MQY76.HKD","SG9999001176.SGD","IBBQ","IE00BFTCPJ56.SGD","IE00B19Z3581.USD","IE00B4R5TH58.HKD","BK4532","BK4585","IE0009355771.USD","TBXU","IE00BJT1NW94.SGD","LU2456880835.USD","IE0002270589.USD","LU1035775433.USD","LU1778281490.HKD","IE00BJJMRZ35.SGD","LU2236285917.USD","SG9999001176.USD","LU1093756325.SGD","BK4023","IE00B19Z9P08.USD","BBH","BIB","LU2237438978.USD","LU2468319806.SGD","LU2089984988.USD","LU1815336091.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660796854","title":"Telix Swings to H1 FY26 Net Profit of US$38 Million; Revenue Rises 22% to Us$477 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2660796854","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660796854?lang=en_us&edition=fundamental","pubTime":"2026-08-20 07:10","pubTimestamp":1787181028,"startTime":"0","endTime":"0","summary":"Telix swings to H1 FY26 net profit of US$38 million; revenue rises 22% to US$477 millionTelix Pharmaceuticals reported H1 2026 revenue of US$477 million, up 22% year over year.Net profit swung to US$3","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260819:nNDLbYKwmX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0289739699.SGD","LU2468319806.SGD","LU0114720955.EUR","LU0823434583.USD","LU0320765992.SGD","LU0109394709.USD","LU2362541273.HKD","IBB","BK4585","LU2362540622.SGD","TBXU","LU0823434740.USD","LU0823416689.USD","BK4139","REGN","BK4588","LU0058720904.USD","LU2362541513.USD","LU1974910355.USD","LU2023250504.SGD","BBH","LU0882574055.USD","LU0053666078.USD","BK7067","LU2106854487.HKD","LU2089984988.USD","LU0889565916.HKD","TLX.AU","IBBQ","LU1917777945.USD","LU2237438978.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660282476","title":"Press Release: Vertex Resource Group Ltd. Reports Second Quarter 2026 Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2660282476","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660282476?lang=en_us&edition=fundamental","pubTime":"2026-08-20 06:31","pubTimestamp":1787178660,"startTime":"0","endTime":"0","summary":"Profit margin %                           28 %       24 %      26 %      23 %. Adjusted EBITDA %                         18 %       13 %      15 %      11 %.   See \"Non-IFRS Financial Measures\"HIGHLIGHTS FOR THE THREE MONTHS ENDED JUNE 30, 2026-- Net revenue increased $1.0 million over prior period while G&A expenses. -- Profit margin improved to 28.4% of net revenue, up from 24.3% in 2025.-- Adjusted EBITDA increased by $2.8 million, or 43.8%, compared to 2025,with Adjusted EBITDA growth in both the Environmental Consulting and. -- Returned to profitability with net income of $1.0 million, representing a. -- Free cash flow increased to $4.6 million from $1.3 million in Q2 2025.HIGHLIGHTS FOR THE SIX MONTHS ENDED JUNE 30, 2026-- Environmental Consulting net revenue increased by 7.8% compared to H1. -- G&A expenses were reduced by 6.5% compared to H1 2025.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1674673691.USD","IE00B19Z3581.USD","BK4139","BK4588","LU0061475181.USD","LU1035775433.USD","SPHQ","IE00B4R5TH58.HKD","LU1674673428.USD","VERX","BK4533","LU2089984988.USD","IDNA","IE00B19Z9P08.USD","IE00BJJMRZ35.SGD","IE00B19Z9Z06.USD","LU2468319806.SGD","VRTX","SG9999013999.USD","LU0320765992.SGD","LU0256863811.USD","IBBQ","LU1069344957.HKD","LU2462157665.USD","IE00B2B36J28.USD","TBXU","SG9999001176.SGD","LU0566484027.USD","PBE","IE00BJT1NW94.SGD","IE00B894F039.SGD","LU0432979614.USD","IBB","LU0889565916.HKD","GNMX","LU0058720904.USD","LU2456880835.USD","BK4532","LU1815336091.USD","LU0417517546.SGD","LU0757428866.USD","BBH","LU0823416689.USD","IE0009355771.USD","IE00BFTCPJ56.SGD","LU0079474960.USD","BIB","LU0109394709.USD","SG9999001176.USD","IE0002141913.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660737004","title":"Crinetics Faces Shareholder Challenges to Vertex Merger Deal","url":"https://stock-news.laohu8.com/highlight/detail?id=2660737004","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660737004?lang=en_us&edition=fundamental","pubTime":"2026-08-20 04:32","pubTimestamp":1787171563,"startTime":"0","endTime":"0","summary":"An update from Crinetics Pharmaceuticals ( ($CRNX) ) is now available. On July 6, 2026, Crinetics agreed to be acquired by Vertex Pharmaceuticals v...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/crinetics-faces-shareholder-challenges-to-vertex-merger-deal?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/crinetics-faces-shareholder-challenges-to-vertex-merger-deal?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0256863811.USD","LU0432979614.USD","IE00B19Z9P08.USD","BK4139","IE00B19Z3581.USD","LU1674673691.USD","PBE","SGXZ57979304.SGD","IBB","LU0289739699.SGD","LU2089984988.USD","IE0009355771.USD","IE00BFTCPJ56.SGD","TBXU","IE00B894F039.SGD","IE0002141913.USD","BIB","IBBQ","IE00B2B36J28.USD","LU2417539215.USD","LU2362541513.USD","BBH","LU1778281490.HKD","IE00BZ9MQY76.HKD","LU0320765992.SGD","LU1815336091.USD","BK4585","IDNA","LU1035775433.USD","IE00B19Z9Z06.USD","SG9999001176.SGD","LU2324357040.USD","LU2456880835.USD","LU1585245621.USD","IE00BJT1NW94.SGD","IE00BJJMRZ35.SGD","SG9999013999.USD","IE00B4R5TH58.HKD","LU2462157665.USD","BK4567","LU1093756168.USD","VERX","BK4588","BK4533","LU0566484027.USD","LU0234570918.USD","LU1069344957.HKD","SG9999001176.USD","GNMX","VRTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660473115","title":"Moderna Inc. Stock Rallies 177.0%, Outperforms Peers","url":"https://stock-news.laohu8.com/highlight/detail?id=2660473115","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660473115?lang=en_us&edition=fundamental","pubTime":"2026-08-20 04:32","pubTimestamp":1787171520,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Moderna Inc. sailed 177.0% to $174.38 on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index rising 0.2% to 26,331.09 and the Dow Jones Industrial Average rising 0.2% to 53,463.05.Moderna Inc. hit a new 52-week high, surpassing its previous peak of $85.60, which the company achieved on July 6th.The stock outperformed some of its peers, as Johnson & Johnson rose 0.8% to $273.41, Pfizer Inc. rose 3.6% to $28.24, and Gilead Sciences Inc. rose 2.90% to $147.60.Trading volume totaled 187.3 million, compared to the 50-day average of 7.3 million.Data source: Dow Jones Market Data, FactSet","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4533","MRNX","GILD","BIB","IE00BSNM7G36.USD","LU1674673428.USD","BK4583","MRNY","LU1934455863.HKD","IE00B19Z3B42.SGD","IBBQ","MEDI","BK4588","SG9999015978.USD","LU0320765992.SGD","LU0861579265.USD","LU0965508806.USD","IE0002270589.USD","LU0965509101.SGD","LU1430594728.SGD","LU0889565916.HKD","SG9999015952.SGD","BK4548","LU0289739699.SGD","LU2324357040.USD","LU0234570918.USD","LU1934455194.USD","LU0965509010.AUD","BK4139","IE00BKVL7J92.USD","IE00B19Z3581.USD","IE00BZ1G4Q59.USD","LU1571399168.USD","LU1585245621.USD","MRNA","BBH","LU0965509283.SGD","LU1934455277.USD","IBB","IDNA","LGHT","LU0122379950.USD","BMED","BK4578","GNOM","TBXU","TMED","LU1778281490.HKD","WDNA","IE00B7SZLL34.SGD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":2,"totalSize":200,"code":"91000000","status":"200"}]}}